Mike Townsend, IDC Health Insights

Mike Townsend Michael Townsend is a Research Manager for IDC Health Insights responsible for Commercial Life Sciences and Life Sciences Business Systems Strategies. He provides research-based advisory and consulting services, as well as market analysis on key topics within the commercial life science industry. Mr. Townsend's research expertise includes sales and marketing, supply chain, manufacturing systems, and emerging technologies and market trends. Mr. Townsend brings 20+ years of engineering and operational management experience at manufacturers serving the Life Sciences industry including Carl Zeiss, Ametek, and Danaher. He served as President and CEO of Dover Instrument Corporation prior to and including its merger with Danaher Corporation. He has been involved in the specification, design and operation of ERP and CRM systems in various management roles. Mr. Townsend holds a Bachelor of Science degree in Mechanical Engineering from the University of Connecticut and an MBA from the University of Connecticut including post-graduate work at Babson College.

Sessions

9:25 AM - 9:55 AM

Data is the New Key Asset: An Interactive Discussion with CDOs

This session puts a spotlight on the challenges all organizations are facing, but that are particularly prevalent in healthcare organizations.  Join the conversation and help to facilitate and encourage change.  We hope by the end of this discussion you will be able to commit to 1-2 things that you can influence in your role over the next year to make progress in more effective management of your data. Discussion points include:  
  • Is it important to develop core technical capabilities in-house or can you rely heavily on consultants and outsourcing?
  • How do you move beyond legacy systems that follow a linear process of development to incorporate more effective methods like agile and sprint?
  • What resources do you need to be able to achieve a global data view to be able to make better decisions?
    • Where do you pull your data from?
    • How do you store it?
    • What is the most effective way to approach data definitions?
  • What are the ethical issues around data and data sharing that you need to be aware of?
  • What can be learned from other industries and companies like Netflix and Coca-Cola about effective data management?

Moderator

  • Mike Townsend

    Mike Townsend Research Manager, Life Sciences Commercial Strategies IDC Health Insights

Speakers

  • Lihua Yu, Ph.D.

    Lihua Yu, Ph.D. President, Chief Data Science Officer H3 Biomedicine Inc.


9:55 AM - 10:20 AM

Real-World Evidence and AI: Where are We Now and How Can We Take the Next Steps Forward to Directly Impact Care?

This session will focus on the kind of real world data that is needed to realize the potential of AI. With so much opportunity for progress, prioritizing projects is a critical step in delivering on results. Speakers will help identify what types of questions are easier to answer and which are harder in order to help you choose the projects that will result in near term ROI. Using case study examples from two therapeutic areas, discussion will cover these questions and more:  
  • What are the most reliable sources of real world data?
  • How does data need to be curated to be useful?
  • Where are we on the path to directly impacting care?
  • What needs to be done to get to the next phase in realizing the potential of AI through the use of real world evidence?

Moderator

  • Mike Townsend

    Mike Townsend Research Manager, Life Sciences Commercial Strategies IDC Health Insights

  • Marisa Co

    Marisa Co Vice President R&D Business Insights & Analytics Bristol-Myers Squibb

Speakers

  • Marisa Co

    Marisa Co Vice President R&D Business Insights & Analytics Bristol-Myers Squibb


Download Latest Agenda